What Are Typical CK Levels During an Active IMNM Flare?
At a Glance
During an active IMNM flare, creatine kinase (CK) often rises into the thousands, commonly about 3,000 to above 10,000 U/L. A CK result alone cannot confirm a flare; clinicians also consider muscle strength, symptoms, kidney tests, and how the level changes over time.
In this answer
3 sections
Normal Creatine Kinase (CK) levels are often cited as being under 200 U/L, but “normal” ranges vary widely based on your sex, race, muscle mass, and the specific laboratory analyzing your blood [1]. You should always look at the specific reference range provided on your own lab report [1]. However, during an active flare of Immune-Mediated Necrotizing Myopathy (IMNM), CK levels are often markedly elevated [2]. It is common for these numbers to reach into the thousands, frequently ranging from 3,000 to over 10,000 U/L when the disease is highly active [2][3].
Understanding the Numbers
CK is an enzyme found inside your muscles. When muscle cells are injured or die—a process called necrosis, which is the primary hallmark of IMNM—large amounts of CK are released into the bloodstream. Studies of adult IMNM patients have found that the median peak CK level during an active disease phase is around 7,020 U/L [4]. Some individual cases in these studies have recorded peak values over 39,000 U/L or even 50,000 U/L [4][2], but it is important to remember that these represent extremes within study cohorts, not standard personal targets.
Your specific antibody subtype can also influence your lab results. Patients who test positive for specific IMNM antibodies—namely the anti-SRP or anti-HMGCR subtypes—tend to show higher baseline and flare CK numbers than those with seronegative IMNM (meaning no currently recognized myositis antibodies are detected) [3][2]. For example, in one study of patients with anti-HMGCR IMNM, average CK levels at diagnosis were nearly 8,000 U/L [3]. However, these ranges overlap significantly between groups, and your individual CK level does not determine your diagnosis or strictly predict your personal disease course.
Interpreting Your Results
Seeing CK numbers jump into the thousands can be concerning, but these high values are a recognized feature of active IMNM [2]. Keep in mind that a single elevated CK test does not automatically confirm a disease flare; CK can temporarily rise due to strenuous exercise, muscle injury, or certain medications [1].
As your immunosuppressant treatments begin to work and immune-mediated muscle injury settles, your CK levels will usually trend downward over time [5][6]. However, your CK level and your physical strength do not always align perfectly. Sometimes, CK levels can remain elevated even as your physical muscle strength improves [7]. Conversely, your CK might return to near-normal levels while you still feel profound weakness, because it takes significant time for damaged muscle tissue to rebuild itself. Your doctor will evaluate your physical strength, physical function, daily symptoms, and lab trends together to guide your care [7].
When to Seek Immediate Medical Attention
While elevated CK is expected in IMNM, massive and rapid muscle breakdown can lead to a dangerous complication called rhabdomyolysis [8]. When too much muscle protein (called myoglobin) floods into your bloodstream, it can cause severe, acute kidney injury [8][9].
Seek emergency medical care if you experience any of the following, as they could be signs of severe kidney or muscle injury:
Common questions in this guide
What CK level is common during an active IMNM flare?
Does a high CK result prove that my IMNM is flaring?
Can my CK improve before my muscle weakness does?
Why does IMNM cause very high CK levels?
When is a high CK level during IMNM an emergency?
Do anti-SRP or anti-HMGCR antibodies affect CK levels?
What other tests may be checked with CK in IMNM?
Related questions
Show more
Get notified when new evidence is published on Immune-mediated necrotizing myopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
Statin-Induced Necrotizing Autoimmune Myopathy: Diagnosis and Treatment Approach.
Srinivasan V, Prabu S, Sfeir JG, Muthusamy K
JCEM case reports 2024; (2(12)):luae227 doi:10.1210/jcemcr/luae227.
PMID: 39659392 - 2
Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series.
Xiong A, Yang G, Song Z, et al.
Therapeutic advances in neurological disorders 2021; (14()):1756286421998918 doi:10.1177/1756286421998918.
PMID: 33786066 - 3
Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
Tan E, Knight J, Khonasti S, et al.
Internal medicine journal 2023; (53(10)):1846-1853 doi:10.1111/imj.16004.
PMID: 36625419 - 4
The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study.
Khoo T, Tan E, Limaye V, et al.
Rheumatology (Oxford, England) 2025; (64(9)):4995-5003 doi:10.1093/rheumatology/keaf238.
PMID: 40347460 - 5
Anti-HMGCR-Antibody-Positive Statin-Induced Myositis: A Pilot Case Series on Treatment with Bempedoic Acid and Immunosuppressive Therapy.
Benucci M, Terenzi R, Li Gobbi F, et al.
Antibodies (Basel, Switzerland) 2025; (14(3)) doi:10.3390/antib14030063.
PMID: 40843675 - 6
Clinical Characteristics and Management of Statin-Associated Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy.
Yoon J, Kim SW, Kim SH, et al.
Journal of clinical medicine 2025; (14(18)) doi:10.3390/jcm14186610.
PMID: 41010829 - 7
Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
Pinal-Fernandez I, Parks C, Werner JL, et al.
Arthritis care & research 2017; (69(2)):263-270 doi:10.1002/acr.22920.
PMID: 27111848 - 8
Diagnostic Approach to Seronegative Autoimmune-Mediated Rhabdomyolysis: A Case Report.
Behzadi C, Neavling N, Kurapati R
Cureus 2026; (18(7)):e113239 doi:10.7759/cureus.113239.
PMID: 42633337 - 9
Severe Rhabdomyolysis in the Setting of Influenza A Infection and Clinically Suspected Anti-signal Recognition Particle-Positive Immune-Mediated Necrotizing Myopathy.
Hoang YNN, Baral S
Cureus 2026; (18(8)):e115167 doi:10.7759/cureus.115167.
PMID: 42787800 - 10
Thrombotic microangiopathy in a patient with anti-signal recognition particle antibody-positive immune-mediated necrotising myopathy: a case report.
Kodera T, Akiyama K, Kubota M, et al.
Modern rheumatology case reports 2026; (10(1)) doi:10.1093/mrcr/rxag009.
PMID: 41615001
This page explains CK results during an IMNM flare for informational purposes and does not constitute medical advice. Ask your treating clinician how to interpret your CK trend and when to seek urgent care.